Chordate Medical
Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider
Chordate Medical Holding AB (publ) ("Chordate") has entered into an agreement for liquidity provision with Lago Kapital ("Lago").
According to the agreement, Lago will provide trading posts in Chordate's stock on both the buy and sell sides in accordance with and within the framework of Nasdaq Stockholm's rules for liquidity provision. The purpose of liquidity provision is to improve liquidity and reduce volatility. Lago's assignment commences on April 19th, 2024.
Datum | 2024-04-18, kl 08:30 |
Källa | MFN |